Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

The Gastrointestinal Tract as a Key Target Organ for the Health-Promoting Effects of Dietary Proanthocyanidins.

Cires MJ, Wong X, Carrasco-Pozo C, Gotteland M.

Front Nutr. 2017 Jan 3;3:57. doi: 10.3389/fnut.2016.00057. Review.

2.

Anticancer Efficacy of Polyphenols and Their Combinations.

Niedzwiecki A, Roomi MW, Kalinovsky T, Rath M.

Nutrients. 2016 Sep 9;8(9). pii: E552. doi: 10.3390/nu8090552. Review.

3.

Glycosylation of plasma IgG in colorectal cancer prognosis.

Theodoratou E, Thaçi K, Agakov F, Timofeeva MN, Štambuk J, Pučić-Baković M, Vučković F, Orchard P, Agakova A, Din FV, Brown E, Rudd PM, Farrington SM, Dunlop MG, Campbell H, Lauc G.

Sci Rep. 2016 Jun 15;6:28098. doi: 10.1038/srep28098.

4.

Dietary intake of flavonoid subclasses and risk of colorectal cancer: evidence from population studies.

He X, Sun LM.

Oncotarget. 2016 May 3;7(18):26617-27. doi: 10.18632/oncotarget.8562.

5.

Habitual intake of flavonoid subclasses and risk of colorectal cancer in 2 large prospective cohorts.

Nimptsch K, Zhang X, Cassidy A, Song M, O'Reilly ÉJ, Lin JH, Pischon T, Rimm EB, Willett WC, Fuchs CS, Ogino S, Chan AT, Giovannucci EL, Wu K.

Am J Clin Nutr. 2016 Jan;103(1):184-91. doi: 10.3945/ajcn.115.117507.

6.

Poncirin Induces Apoptosis in AGS Human Gastric Cancer Cells through Extrinsic Apoptotic Pathway by up-Regulation of Fas Ligand.

Saralamma VV, Nagappan A, Hong GE, Lee HJ, Yumnam S, Raha S, Heo JD, Lee SJ, Lee WS, Kim EH, Kim GS.

Int J Mol Sci. 2015 Sep 18;16(9):22676-91. doi: 10.3390/ijms160922676.

7.

Role of the Aryl Hydrocarbon Receptor in Colon Neoplasia.

Xie G, Raufman JP.

Cancers (Basel). 2015 Jul 31;7(3):1436-46. doi: 10.3390/cancers7030847.

8.

Induction of cellular and molecular immunomodulatory pathways by vitamin A and flavonoids.

Patel S, Vajdy M.

Expert Opin Biol Ther. 2015;15(10):1411-28. doi: 10.1517/14712598.2015.1066331. Review.

9.

Inflammatory bowel disease associates with proinflammatory potential of the immunoglobulin G glycome.

Trbojević Akmačić I, Ventham NT, Theodoratou E, Vučković F, Kennedy NA, Krištić J, Nimmo ER, Kalla R, Drummond H, Štambuk J, Dunlop MG, Novokmet M, Aulchenko Y, Gornik O, Campbell H, Pučić Baković M, Satsangi J, Lauc G; IBD-BIOM Consortium..

Inflamm Bowel Dis. 2015 Jun;21(6):1237-47. doi: 10.1097/MIB.0000000000000372.

10.

The flavonoid nobiletin inhibits tumor growth and angiogenesis of ovarian cancers via the Akt pathway.

Chen J, Chen AY, Huang H, Ye X, Rollyson WD, Perry HE, Brown KC, Rojanasakul Y, Rankin GO, Dasgupta P, Chen YC.

Int J Oncol. 2015;46(6):2629-38. doi: 10.3892/ijo.2015.2946.

11.

Bioactive compounds produced by gut microbial tannase: implications for colorectal cancer development.

López de Felipe F, de Las Rivas B, Muñoz R.

Front Microbiol. 2014 Dec 5;5:684. doi: 10.3389/fmicb.2014.00684.

12.

Phenolic metabolites and substantial microbiome changes in pig feces by ingesting grape seed proanthocyanidins.

Choy YY, Quifer-Rada P, Holstege DM, Frese SA, Calvert CC, Mills DA, Lamuela-Raventos RM, Waterhouse AL.

Food Funct. 2014 Sep;5(9):2298-308. doi: 10.1039/c4fo00325j.

13.

HSP90 Inhibitors, Geldanamycin and Radicicol, Enhance Fisetin-Induced Cytotoxicity via Induction of Apoptosis in Human Colonic Cancer Cells.

Wu MS, Lien GS, Shen SC, Yang LY, Chen YC.

Evid Based Complement Alternat Med. 2013;2013:987612. doi: 10.1155/2013/987612.

14.

Model selection approach suggests causal association between 25-hydroxyvitamin D and colorectal cancer.

Zgaga L, Agakov F, Theodoratou E, Farrington SM, Tenesa A, Dunlop MG, McKeigue P, Campbell H.

PLoS One. 2013 May 24;8(5):e63475. doi: 10.1371/journal.pone.0063475.

15.

Inhibitory effect of baicalin and baicalein on ovarian cancer cells.

Chen J, Li Z, Chen AY, Ye X, Luo H, Rankin GO, Chen YC.

Int J Mol Sci. 2013 Mar 15;14(3):6012-25. doi: 10.3390/ijms14036012.

16.

Dietary flavonoid intake and risk of stomach and colorectal cancer.

Woo HD, Kim J.

World J Gastroenterol. 2013 Feb 21;19(7):1011-9. doi: 10.3748/wjg.v19.i7.1011. Review.

17.

Statin use and association with colorectal cancer survival and risk: case control study with prescription data linkage.

Lakha F, Theodoratou E, Farrington SM, Tenesa A, Cetnarskyj R, Din FV, Porteous ME, Dunlop MG, Campbell H.

BMC Cancer. 2012 Oct 22;12:487. doi: 10.1186/1471-2407-12-487.

18.

Kaempferol nanoparticles achieve strong and selective inhibition of ovarian cancer cell viability.

Luo H, Jiang B, Li B, Li Z, Jiang BH, Chen YC.

Int J Nanomedicine. 2012;7:3951-9. doi: 10.2147/IJN.S33670.

19.

The association of dietary intake of purine-rich vegetables, sugar-sweetened beverages and dairy with plasma urate, in a cross-sectional study.

Zgaga L, Theodoratou E, Kyle J, Farrington SM, Agakov F, Tenesa A, Walker M, McNeill G, Wright AF, Rudan I, Dunlop MG, Campbell H.

PLoS One. 2012;7(6):e38123. doi: 10.1371/journal.pone.0038123.

20.

Instrumental variable estimation of the causal effect of plasma 25-hydroxy-vitamin D on colorectal cancer risk: a mendelian randomization analysis.

Theodoratou E, Palmer T, Zgaga L, Farrington SM, McKeigue P, Din FV, Tenesa A, Davey-Smith G, Dunlop MG, Campbell H.

PLoS One. 2012;7(6):e37662. doi: 10.1371/journal.pone.0037662.

Supplemental Content

Support Center